2021. Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab – a single centre cohort study. Swiss Medical Weekly. 151, 3132 (Aug. 2021), w20550. DOI:https://doi.org/10.4414/smw.2021.20550.